Onesource Specialty Pharma Share Price
1544.20-31.50 (-2.00%)
-18.68% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 30.48% | 30.48% | 29.93% | 29.77% | 29.79% | 34.25% |
| 19.19% | 17.50% | 19.24% | 19.39% | 18.69% | 18.54% |
| 10.39% | 10.48% | 9.65% | 9.36% | 8.90% | 9.58% |
| 12.98% | 10.13% | 9.02% | 8.99% | 9.06% | 8.32% |
| 26.96% | 31.41% | 32.16% | 32.49% | 33.56% | 29.31% |
Bulk & block deals
Name
Fidelity Securities Fund: Fidelity Blue Chip Growth Fund
Authum Investment & Infrastructure Limited
Nova Global Opportunities Fund Pcc - Touchstone
Authum Investment & Infrastructure Limited
Karuna Business Solutions Llp
Amansa Holding Private Ltd.
Medella Holdings Pte. Ltd.
Cpt Research & Mgmt Co T/A Cpt World Investors
Motilal Oswal Mutual Fund A/C Motilal Oswal Large And Midcap Fund
Medella Holdings Pte. Ltd.
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 21 Apr 2026 | Purchase | 308.70 Cr | ₹1,530 | 20.18 L | Bulk | 1.759493 | NSE |
| 21 Apr 2026 | Purchase | 26.88 Cr | ₹1,556.69 | 1.73 L | Bulk | 0.150574 | NSE |
| 21 Apr 2026 | Sell | 161.86 Cr | ₹1,530 | 10.58 L | Bulk | 0.922539 | NSE |
| 21 Apr 2026 | Sell | 145.36 Cr | ₹1,530.09 | 9.50 L | Bulk | 0.828443 | NSE |
| 17 Nov 2025 | Purchase | 34.70 Cr | ₹1,735 | 2 L | Block | 0.174409 | NSE |
| 17 Nov 2025 | Sell | 34.70 Cr | ₹1,735 | 2 L | Block | 0.174409 | NSE |
| 15 May 2025 | Sell | 138.65 Cr | ₹1,568.04 | 8.84 L | Bulk | 0.771071 | BSE |
| 31 Jan 2025 | Purchase | 176.16 Cr | ₹1,545 | 11.40 L | Bulk | 0.994279 | NSE |
| 31 Jan 2025 | Purchase | 163.04 Cr | ₹1,545 | 10.55 L | Bulk | 0.920225 | NSE |
| 31 Jan 2025 | Sell | 301.53 Cr | ₹1,552.90 | 19.42 L | Bulk | 1.693293 | NSE |
Insider trading & SAST
Client name
Pronomz Ventures Llp & Pacs
Tenshi Pharmaceuticals Pvt Ltd & Pacs
Tenshi Pharmaceuticals Pvt Ltd
Tenshi Pharmaceuticals Pvt Ltd & Pacs
Pronomz Ventures Llp & Pacs
Tenshi Pharmaceuticals Pvt Ltd & Pacs
Pronomz Ventures Llp
Pronomz Ventures Llp
Tenshi Pharmaceuticals Private Limited
Tenshi Pharmaceuticals Private Limited
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17 Feb 2026 | Promoter | Acquisition | 0.04 | 30.23 | 0 | — | 45 K | 02 Feb 2026 | Market | 3,46,50,105 | SAST | 29(2) | — |
| 17 Feb 2026 | Promoter | Acquisition | 0.07 | 30.48 | 0 | — | 85 K | 04 Feb 2026 | Market | 3,49,40,105 | SAST | 29(2) | — |
| 17 Feb 2026 | Promoter | Acquisition | 0.18 | 30.41 | 0 | — | 2.05 L | 02 Feb 2026 | Market | 3,48,55,105 | SAST | 29(2) | — |
| 16 Feb 2026 | Promoter | Acquisition | 0.07 | 30.17 | 0 | — | 75 K | 30 Jan 2026 | Market | 3,45,71,199 | SAST | 29(2) | — |
| 16 Feb 2026 | Promoter | Acquisition | 0.03 | 30.19 | 0 | — | 33.91 K | 30 Jan 2026 | Market | 3,46,05,105 | SAST | 29(2) | — |
| 10 Feb 2026 | Promoter | Acquisition | 0.17 | 30.1 | 0 | — | 2 L | 28 Jan 2026 | Market | 3,44,96,199 | SAST | 29(2) | — |
| 06 Feb 2026 | Promoter Group | Acquisition | 0.03926 | 2.41 | 5.10 Cr | ₹1,132.23 | 45 K | 02 Feb 2026 | Market Purchase | 27,61,308 | Insider Trading | — | Equity Shares |
| 06 Feb 2026 | Promoter Group | Acquisition | 0.029581 | 2.37 | 4.05 Cr | ₹1,194.02 | 33.91 K | 30 Jan 2026 | Market Purchase | 27,16,308 | Insider Trading | — | Equity Shares |
| 06 Feb 2026 | Promoter | Acquisition | 0.065433 | 18.15 | 8.71 Cr | ₹1,161.78 | 75 K | 30 Jan 2026 | Market Purchase | 2,07,99,714 | Insider Trading | — | Equity Shares |
| 06 Feb 2026 | Promoter | Acquisition | 0.17885 | 18.33 | 23.88 Cr | ₹1,164.76 | 2.05 L | 02 Feb 2026 | Market Purchase | 2,10,04,714 | Insider Trading | — | Equity Shares |